Cargando…
Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
BACKGROUND: This study examined Sal-like protein (SALL)3 methylation profiles of head and neck cancer (HNSCC) patients at diagnosis and follow-up and evaluated their prognostic significance and value as a biomarker. SALL3 expression was examined in a panel of cell lines by quantitative reverse trans...
Autores principales: | Misawa, Kiyoshi, Mochizuki, Daiki, Imai, Atsushi, Misawa, Yuki, Endo, Shiori, Mima, Masato, Kawasaki, Hideya, Carey, Thomas E., Kanazawa, Takeharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469057/ https://www.ncbi.nlm.nih.gov/pubmed/28616099 http://dx.doi.org/10.1186/s13148-017-0363-1 |
Ejemplares similares
-
Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018) -
Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
por: Mochizuki, Daiki, et al.
Publicado: (2018) -
Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018) -
The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2018) -
Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2016)